NO175979C - Analogifremgangsmåte for fremstilling av terapeutisk aktive pteridiner - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive pteridiner

Info

Publication number: NO175979C
Authority: NO; Norway
Prior art keywords: pteridines; group; preparation; substituted; carbon atom
Prior art date: 1988-10-01

Application number

NO893879A

Other languages

English (en)

Norwegian (no)

Other versions

NO893879L (no

NO175979B (no

NO893879D0 (no

Inventor

Armin Heckel

Jorg Lebsanft

Uwe Bamberger

Avner Ramu

Original Assignee

Thomae Gmbh Dr K

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-10-01

Filing date

1989-09-29

Publication date

1995-01-11

1989-09-29 Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K

1989-09-29 Publication of NO893879D0 publication Critical patent/NO893879D0/no

1990-04-02 Publication of NO893879L publication Critical patent/NO893879L/no

1994-10-03 Publication of NO175979B publication Critical patent/NO175979B/no

1995-01-11 Publication of NO175979C publication Critical patent/NO175979C/no

Links

150000003195 pteridines Chemical class 0.000 title abstract 4
238000000034 method Methods 0.000 title abstract 2
125000004432 carbon atom Chemical group C* 0.000 abstract 4
229910052799 carbon Inorganic materials 0.000 abstract 3
125000000217 alkyl group Chemical group 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
229910052757 nitrogen Inorganic materials 0.000 abstract 2
125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
206010070834 Sensitisation Diseases 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
230000000973 chemotherapeutic effect Effects 0.000 abstract 1
238000002512 chemotherapy Methods 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
229930014626 natural product Natural products 0.000 abstract 1
125000003884 phenylalkyl group Chemical group 0.000 abstract 1
CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 abstract 1
-1 pyrrolidino, piperidino Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO893879A 1988-10-01 1989-09-29 Analogifremgangsmåte for fremstilling av terapeutisk aktive pteridiner NO175979C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE3833393A DE3833393A1 (de)	1988-10-01	1988-10-01	Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel

Publications (4)

Publication Number	Publication Date
NO893879D0 NO893879D0 (no)	1989-09-29
NO893879L NO893879L (no)	1990-04-02
NO175979B NO175979B (no)	1994-10-03
NO175979C true NO175979C (no)	1995-01-11

Family

ID=6364156

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO893879A NO175979C (no)	1988-10-01	1989-09-29	Analogifremgangsmåte for fremstilling av terapeutisk aktive pteridiner

Country Status (19)

Country	Link
EP (1)	EP0362645B1 (fr)
JP (1)	JPH02256676A (fr)
KR (1)	KR910006289A (fr)
AT (1)	ATE106728T1 (fr)
AU (1)	AU620645B2 (fr)
DD (1)	DD299062A5 (fr)
DE (2)	DE3833393A1 (fr)
DK (1)	DK480489A (fr)
ES (1)	ES2056174T3 (fr)
FI (1)	FI92699C (fr)
HU (1)	HU205761B (fr)
IL (1)	IL91814A (fr)
MX (1)	MX9203034A (fr)
NO (1)	NO175979C (fr)
NZ (1)	NZ230833A (fr)
PT (1)	PT91836B (fr)
SU (1)	SU1720491A3 (fr)
UA (1)	UA8028A1 (fr)
ZA (1)	ZA897414B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7276506B2 (en)	1998-12-28	2007-10-02	4 Aza Bioscience Nv	Immunosuppressive effects of pteridine derivatives
ES2229803T3 (es) *	1998-12-28	2005-04-16	4 Aza Bioscience Nv	Efectos inmunosupresivos de derivados de pteridina.
DE10202468A1 (de) *	2002-01-23	2004-09-30	Faustus Forschungs Cie. Translational Cancer Research Gmbh	Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
DE602004008304T2 (de) *	2003-09-12	2008-05-08	4 Aza Ip Nv	Pteridin-derivate zur behandlung von erkrankungen im zusammenhang mit tnf-alpha
ES2293354T3 (es) *	2003-10-17	2008-03-16	4 Aza Ip Nv	Derivados de pteridina sustituidos por heterociclos y su uso en terapia.
RU2447074C2 (ru) *	2005-05-12	2012-04-10	Тиботек Фармасьютикалз Лтд.	Птеридины, полезные в качестве ингибиторов hcv, и способы получения птеридинов
US10144736B2 (en)	2006-07-20	2018-12-04	Gilead Sciences, Inc.	Substituted pteridines useful for the treatment and prevention of viral infections
US9259426B2 (en)	2006-07-20	2016-02-16	Gilead Sciences, Inc.	4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
CU20180011A7 (es)	2015-03-04	2018-06-05	Gilead Sciences Inc	Composiciones farmacéuticas que comprenden compuestos derivados de diaminopirido (3,2-d) como moduladores de receptor de tipo toll
KR20160003575A (ko)	2015-11-09	2016-01-11	정민시	발전기용 동력전달장치
US10640499B2 (en)	2016-09-02	2020-05-05	Gilead Sciences, Inc.	Toll like receptor modulator compounds
PL3507276T3 (pl)	2016-09-02	2022-02-21	Gilead Sciences, Inc.	Związki modulatory receptorów toll-podobnych
TWI751517B (zh)	2019-04-17	2022-01-01	美商基利科學股份有限公司	類鐸受體調節劑之固體形式
TW202210480A (zh)	2019-04-17	2022-03-16	美商基利科學股份有限公司	類鐸受體調節劑之固體形式
TWI879779B (zh)	2019-06-28	2025-04-11	美商基利科學股份有限公司	類鐸受體調節劑化合物的製備方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3574206A (en) *	1965-04-15	1971-04-06	Boehringer Sohn Ingelheim	2,7-dimorpholino-4-amino-6-phenyl-pteridines
NL129630C (fr) *	1966-10-14
DE1617336C2 (de) *	1966-11-25	1982-07-01	C.H. Boehringer Sohn, 6507 Ingelheim	Arzneimittel gegen Angina pectoris
DE1795515A1 (de) *	1967-08-18	1972-03-30	Thomae Gmbh Dr K	Verfahren zur Herstellung von neuen Pteridinen
DE1795516A1 (de) *	1967-12-15	1972-01-27	Thomae Gmbh Dr K	4-AEthanolisopropanolamino-2-(2'-methylmorpholino)-7-morpholino-6-phenyl-pteridin
DE1921308A1 (de) *	1969-04-25	1971-01-07	Boehringer Sohn Ingelheim	Herzwirksame Zubereitungen
US4767761A (en) *	1987-11-04	1988-08-30	Dana-Farber Cancer Institute, Inc.	Ornithine derivatives and their use as methotrexate-resistant cell inhibitors

1988
- 1988-10-01 DE DE3833393A patent/DE3833393A1/de not_active Withdrawn
1989
- 1989-09-23 ES ES89117610T patent/ES2056174T3/es not_active Expired - Lifetime
- 1989-09-23 DE DE58907824T patent/DE58907824D1/de not_active Expired - Fee Related
- 1989-09-23 AT AT89117610T patent/ATE106728T1/de not_active IP Right Cessation
- 1989-09-23 EP EP89117610A patent/EP0362645B1/fr not_active Expired - Lifetime
- 1989-09-26 AU AU41749/89A patent/AU620645B2/en not_active Ceased
- 1989-09-28 IL IL9181489A patent/IL91814A/en not_active IP Right Cessation
- 1989-09-28 PT PT91836A patent/PT91836B/pt not_active IP Right Cessation
- 1989-09-29 KR KR1019890014002A patent/KR910006289A/ko not_active Ceased
- 1989-09-29 ZA ZA897414A patent/ZA897414B/xx unknown
- 1989-09-29 DD DD89333128A patent/DD299062A5/de not_active IP Right Cessation
- 1989-09-29 DK DK480489A patent/DK480489A/da not_active Application Discontinuation
- 1989-09-29 NZ NZ230833A patent/NZ230833A/en unknown
- 1989-09-29 UA UA4742036A patent/UA8028A1/uk unknown
- 1989-09-29 FI FI894615A patent/FI92699C/fi not_active IP Right Cessation
- 1989-09-29 HU HU895131A patent/HU205761B/hu not_active IP Right Cessation
- 1989-09-29 SU SU894742036A patent/SU1720491A3/ru active
- 1989-09-29 NO NO893879A patent/NO175979C/no unknown
- 1989-09-29 JP JP1255126A patent/JPH02256676A/ja active Pending
1992
- 1992-06-19 MX MX9203034A patent/MX9203034A/es unknown

Also Published As

Publication number	Publication date
ZA897414B (en)	1991-06-26
SU1720491A3 (ru)	1992-03-15
HU205761B (en)	1992-06-29
AU4174989A (en)	1990-04-05
MX9203034A (es)	1992-07-01
FI92699B (fi)	1994-09-15
PT91836A (pt)	1990-04-30
PT91836B (pt)	1995-07-18
ATE106728T1 (de)	1994-06-15
NO893879L (no)	1990-04-02
EP0362645A2 (fr)	1990-04-11
KR910006289A (ko)	1991-04-29
FI894615A7 (fi)	1990-04-02
EP0362645B1 (fr)	1994-06-08
UA8028A1 (uk)	1995-12-26
DK480489D0 (da)	1989-09-29
FI92699C (fi)	1994-12-27
IL91814A (en)	1994-02-27
IL91814A0 (en)	1990-06-10
JPH02256676A (ja)	1990-10-17
NZ230833A (en)	1991-05-28
NO175979B (no)	1994-10-03
DD299062A5 (de)	1992-03-26
DE3833393A1 (de)	1990-04-05
NO893879D0 (no)	1989-09-29
DK480489A (da)	1990-04-02
FI894615A0 (fi)	1989-09-29
HUT52504A (en)	1990-07-28
AU620645B2 (en)	1992-02-20
ES2056174T3 (es)	1994-10-01
EP0362645A3 (fr)	1992-03-25
DE58907824D1 (de)	1994-07-14

Publication	Publication Date	Title
NO175979C (no)	1995-01-11	Analogifremgangsmåte for fremstilling av terapeutisk aktive pteridiner
DE19775091I2 (de)	2007-05-24	Therapeutische heterocyclische Verbindungen
ES8707238A1 (es)	1987-07-16	Procedimiento para preparar pteridinas
ES390924A1 (es)	1974-04-01	Procedimiento para la preparacion de derivados del acido nicotinico.
MY129935A (en)	2007-05-31	Dihydropyridine derivatives useful in antitumor therapy
ES345994A1 (es)	1969-01-16	Procedimiento para la obtencion de nuevas pteridinas.
GB1405767A (en)	1975-09-10	Method formulation and pharmaceutical composition for reducing plasma lipid levels
GB1320548A (en)	1973-06-13	Nitrofurylaminoalkoxy-pyrimidines
ES345991A1 (es)	1969-01-16	Procedimiento para la obtencion de nuevas pteridinas.
GB1341170A (en)	1973-12-19	Alkyl sulphonic acid esters of 1,3,2-oxazaphospha-cyclic compounds
ES304710A1 (es)	1964-12-01	Procedimiento para la preparaciën de 1,3,5-triacinas
GB1416248A (en)	1975-12-03	Anthraquinone derivatives
ES485333A1 (es)	1980-07-01	Procedimiento para preparar derivados 5,6,7,8-tetrahidro-4 (3h)-quinazolinonicos y sus sales
GB1085922A (en)	1967-10-04	Improvements in and relating to therapeutic compositions containing 2-amino-oxazolin-4-one derivatives, novel derivatives of this type and process for preparing same
FR2670492B1 (fr)	1994-11-04	Nouveaux derives d'aminoalkylcetone, leur procede de preparation et leurs applications en therapeutique.